XP

Xincheng Private Equity

Description

Xincheng Private Equity is a private securities investment fund manager.

Investor Profile

Xincheng Private Equity has backed more than 3 startups, with 2 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Seed rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Pharmaceutical.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xincheng Private Equity frequently co-invest with?

GSR United Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Haiwang Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Co-Investments: 2
Co-Investments: 1
Asymchem Laboratories (Tianjin)
Asia, Guangdong, China, Tianjin
Co-Investments: 1
CC
Asia, Liaoning, China, Chaoyang
Co-Investments: 1
Sino Biological
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Xincheng Private Equity?

Kerui Biopharmaceuticals

Suzhou, Jiangsu, China

Kerui Biopharmaceuticals is an innovative company that specializes in medical research and technical services.

BiotechnologyMedical
SeedJan 16, 2026
Hyperway Pharm

Chengdu, Sichuan, China

Hyperway Pharm IS A Pharmaceutical research and development production enterprise

Health CarePharmaceutical
Series BOct 22, 2025
Amount Raised: $28,071,357
Jinling Biopharma

Suzhou, Jiangsu, China

Jinling Bio provides medical research, experimental development, and medical technology innovation services.

Health CareMedical
SeedSep 8, 2025
Enokiko

Pudong, Shandong, China

Enokiko is a provider of synthetic biology platforms oriented to the study, & manufacturing of environmentally friendly biological products.

BiopharmaBiotechnologyMedical
Series AMar 3, 2025
Amount Raised: $20,589,971
Rigerna

Fengtai, Beijing, China

Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues.

BiopharmaHealth CarePharmaceutical
SeedOct 21, 2024
Amount Raised: $14,046,917
Bio-Link

Shanghai, Shanghai, China

Bio-Link is a drug development company that offers solutions for the life science industry.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series AFeb 21, 2024

Find More Investors Like Xincheng Private Equity

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Xincheng Private Equity | Pipeseed